Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration.

To investigate the prevalence and genetic characteristics of geographic atrophy (GA) among elderly Japanese with advanced age-related macular degeneration (AMD) in a clinic-based study.Two-hundred and ninety consecutive patients with advanced AMD were classified into typical neovascular AMD, polypoi...

Full description

Bibliographic Details
Published in:	PLoS ONE
Main Authors:	Yoichi Sakurada, Seigo Yoneyama, Atsushi Sugiyama, Naohiko Tanabe, Wataru Kikushima, Fumihiko Mabuchi, Atsuki Kume, Takeo Kubota, Hiroyuki Iijima
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-01-01
Online Access:	http://europepmc.org/articles/PMC4769020?pdf=render

Similar Items

Association between Polygenic Risk Score and One-Year Outcomes Following As-Needed Aflibercept Therapy for Exudative Age-Related Macular Degeneration
by: Taiyo Shijo, et al.
Published: (2020-09-01)

Characteristics of intermediate age-related macular degeneration with hyperreflective foci
by: Wataru Kikushima, et al.
Published: (2022-11-01)

A Treat-and-Extend Regimen of Intravitreal Brolucizumab for Exudative Age-Related Macular Degeneration Refractory to Aflibercept: A 12-Month Result
by: Wataru Kikushima, et al.
Published: (2023-04-01)

Short-Term Outcomes of Three Consecutive Monthly Loading Administrations of Aflibercept 8 Mg for Treatment-Naïve Exudative Age-Related Macular Degeneration
by: Shuhei Hosoda, et al.
Published: (2025-03-01)

Comparison of the 1-Year Visual and Anatomical Outcomes between Subthreshold Red (670 nm) and Yellow (577 nm) Micro-Pulse Laser Treatment for Diabetic Macular Edema
by: Wataru Kikushima, et al.
Published: (2021-10-01)

Geographic Atrophy in Age-Related Macular Degeneration
by: Tiarnan D.L. Keenan, BM BCh, PhD
Published: (2023-09-01)

Comparison of Outcomes between 3 Monthly Brolucizumab and Aflibercept Injections for Polypoidal Choroidal Vasculopathy
by: Yoshiko Fukuda, et al.
Published: (2021-09-01)

Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus
by: Atsuki Kume, et al.
Published: (2020-07-01)

Comparison of one-year real-world outcomes between red (670 nm) subthreshold micropulse laser treatment and intravitreal aflibercept injection for treatment-naïve diabetic macular edema
by: Wataru Kikushima, et al.
Published: (2025-02-01)

Recent Advances in Imaging Macular Atrophy for Late-Stage Age-Related Macular Degeneration
by: Anny M. S. Cheng, et al.
Published: (2023-12-01)

Inflammatory Factors of Macular Atrophy in Eyes With Neovascular Age-Related Macular Degeneration Treated With Aflibercept
by: Tomohito Sato, et al.
Published: (2021-10-01)

Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
by: Grace A. Borchert, et al.
Published: (2024-07-01)

A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
by: Kenji Yamashiro, et al.
Published: (2017-08-01)

Characteristics of geographic atrophy secondary to age-related macular degeneration in Korean patients
by: Sang Min Park, et al.
Published: (2025-09-01)

Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration
by: Rishi P Singh, et al.
Published: (2025-07-01)

Accelerated Brain Atrophy, Microstructural Decline and Connectopathy in Age-Related Macular Degeneration
by: Jacques A. Stout, et al.
Published: (2024-01-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
by: Grace A. Borchert, et al.
Published: (2023-08-01)

Deep learning to detect macular atrophy in wet age-related macular degeneration using optical coherence tomography
by: Wei Wei, et al.
Published: (2023-05-01)

Real-World Outcomes of Brolucizumab Treatment in Japanese Patients with Neovascular Age-Related Macular Degeneration: A 12-Month, Multicenter Study
by: Masayuki Ohnaka, et al.
Published: (2025-05-01)

OCT predictors of retinal atrophy in neovascular age-related macular degeneration treated with aflibercept
by: Oscar M. Gagliardi, et al.
Published: (2025-04-01)

Advancements in Imaging and Therapeutic Options for Dry Age-Related Macular Degeneration and Geographic Atrophy
by: Andrea Servillo, et al.
Published: (2024-06-01)

Deep Learning Approaches for Detecting of Nascent Geographic Atrophy in Age-Related Macular Degeneration
by: Heming Yao, PhD, et al.
Published: (2024-05-01)

Population Pharmacokinetics of Pegcetacoplan in Patients with Geographic Atrophy or Neovascular Age-related Macular Degeneration
by: Ryan L. Crass, PharmD, et al.
Published: (2025-03-01)

Association of Polyp Regression after Loading Phase with 12-Month Outcomes of Eyes with Polypoidal Choroidal Vasculopathy
by: Misa Kimura, et al.
Published: (2024-05-01)

Targeted High-Density Microperimetry Testing of Nascent Geographic Atrophy in Age-Related Macular Degeneration
by: Zhichao Wu, BAppSc(Optom), PhD, et al.
Published: (2024-03-01)

Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.
by: Felix Grassmann, et al.
Published: (2015-01-01)

Variation in Mesopic Retinal Sensitivity Relative to Distance from Geographic Atrophy in Age-Related Macular Degeneration
by: Souvick Mukherjee, PhD, et al.
Published: (2025-11-01)

Automatic Quantification Software for Geographic Atrophy Associated with Age-Related Macular Degeneration: A Validation Study
by: José M. Ruiz-Moreno, et al.
Published: (2020-01-01)

Current advances in multimodal imaging in geographic atrophy secondary to age-related macular degeneration: A review
by: Amy C. Cohn, et al.
Published: (2024-12-01)

Levodopa is associated with reduced development of new-onset geographic atrophy in patients with age-related macular degeneration
by: Kyle S. Chan, et al.
Published: (2024-11-01)

Rehabilitation Methods for Patients with Geographic Atrophy due to Age-Related Macular Degeneration and Effects of Rehabilitation on Quality of Life
by: Damla Erginturk Acar, et al.
Published: (2023-01-01)

Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration
by: Katarzyna Żuber-Łaskawiec, et al.
Published: (2024-05-01)

Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen
by: Hiroyuki Kamao, et al.
Published: (2021-01-01)

A comparative study of choroidal structural features in eyes with central macular atrophy related to Stargardt disease and non-exudative age-related macular degeneration
by: Figen Batıoğlu, et al.
Published: (2024-11-01)

Charles Bonnet syndrome in patients with geographic atrophy secondary to age-related macular degeneration: a cross-sectional study
by: Nathalie Skovgaard Eriksen, et al.
Published: (2025-01-01)

Analyzing Age-Related Macular Degeneration Progression in Patients with Geographic Atrophy Using Joint Autoencoders for Unsupervised Change Detection
by: Guillaume Dupont, et al.
Published: (2020-06-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
by: Sayah DN, et al.
Published: (2023-12-01)

Real-World Outcomes in Pre-Existing Neovascular Age-Related Macular Degeneration Subjects Undergoing Avacincaptad Therapy for Geographic Atrophy
by: Rush RB, et al.
Published: (2024-12-01)

Electrophysiological signs of retinal cone remodeling in geographic atrophy of the pigment epithelium in patients with non-exudative age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-09-01)

Geographic Atrophy Secondary to Subclinical Angioid Streaks in Age-Related Macular Degeneration: Progression of the Disease at 2-Year Follow-Up
by: Riccardo Sacconi, et al.
Published: (2025-03-01)